Angiogenesis is an essential event in the tumor growth and Metastasis. The aim of our research is to study the effect of Elaeagnus angustifolia and Nepeta crispa extracts on anti-angiogenic activities in human umbilical endothelial cells (HUVEC). Hydroalcoholic extract and its successive hexane, ethyl acetate, chloroform and aqueous fractions were used in different concentration by three dimensional cytodex-collagen model. Hydroalcoholic extracts of E. angustifolia flower in 200 µg/ml and N. crispa aerial part in 400 µg/ml potentialy inhibited angiogenesis activity of HUVEC and 10 µg/ml both of ethyl acetate and chloroform fractions exerted prevention of this activity. Therefore, E. angustifolia flower and N. crispa aerial part could be candidate for therapeutic or preventive activity against angiogenesis related disorders.
INTRODUCTION
The formation of Neovascularization from an existing capillaries network, angiogenesis, is a process involving the proliferation, extracellular matrix degradation, survival, migration, and anastomosis of endothelial cells (ECs). It is associated with a number of physiologic and pathologic conditions including malignancies, diabetic retinopathy, rheumatoid arthritis and skin diseases, particularly psoriasis (Creamer et al., 2002) .
Angiogenesis, tightly modulated through a balance of positive and negative regulatory factors, is to operate by pro-angiogenic growth factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), and epithelial growth factor (EGF) (Hanahan and Folkman, 1996) , which in turn induce activation of their respective receptors on the surface of endothelial cells, resulting in angiogenesis (Hynu-JooJung et al., 2006) Identification of endostatin as an inhibitor of angiogenesis (Folkman, *Corresponding author. E-mail: khpiri@gmail.com. Tel: 00980198130783. Fax: 0098811 4224012.
2006), a variety of anti-angiogenic compounds, such as soybean trypsin inhibitor (Shakiba et al., 2007) , withaferin A from withania somniferous (Mohan et al., 2004) , a peptide from shark cartilage (Hassan et al., 2005) and green tea catechin (Tang et al., 2007) have been isolated from natural products. (Keshavarz et al., 2010) . Therefore, identification of new agents that inhibit growth in endothelial cells could have potential to inhibit tumor angiogenesis and subsequently repress tumor growth. No doubts, plants are the source of many bioactive compounds and a lot of them may possess significant biological activity.
However, besides enthusiasm which many people uncritically express towards natural products, there are several problems which should be discussed (Dulkan, 2005) . The genus Elaeagnus and Nepeta respectively belongs to the family Elaeagnaceae and Lamiaceae, which comprises some important species that growing in Iran, with the common local name Senjed and Mofarrah (because of its sweet odor) has been of great interest to Iranian traditional medicine, especially in Hamedan province (Mozaffarian, 1996) .The major compound of E. angustifolia flower show ethyl cinnamate, 2-phenyl-ethyl benzoate, 2-phenyl-ethyl isovalerate, nerolidole, squalene and acetophenone (Bucur et al., 2007) and the main constituents in N. crispa aerial part indicate 1,8-cineol (47.9%) and 4aα,7α,7aβ-nepetalactone (20.3%) (Sefidkon and Jamzad, 2006) .
There are various reports showing beneficial effects of E. angustifolia and N. crispa such as antioxidant, antiinflammatory, antifungal, antibacterial, antinociceptive activities, sedative, relaxant, carminative, restorative tonic for nervous, respiratory disorders and prevention of heart diseases (Mozaffarian, 1996; Ahmadiani et al., 2000; Sonboli and Salehi, 2004; Bucur et al., 2007) . This work evaluates the in vitro antiangiogenic activity of extracts and fractions of E. angustifolia and N. crispa.
MATERIALS AND METHODS
Rat tail collagen (Sigma Chemical Co.), Dulbecco's modified minimum essential medium (DMEM), RPMI 1640, fetal bovine serum (FBS) (Gibco, New York, USA), dextran-coated cytodex 3 microcarriers (Amersham Pharmasia Biotech) and Human umbilical vein endothelial cells (HUVEC) were obtained from the American Type Culture Collection, lactate dehydrogenase (LDH) cytotoxicity assay kit (Roch Chemical Co.).
Plant material
Flowers and aerial parts of respectively E. angustifolia and N. crispa were collected in July from Hamedan province and then identified by the Agricultural College of Bu-Ali sina University The plants were cleaned, and dried at 25°C at room condition.
Preparation of hydroalcohic extract and its fractions
The powder of plants was extracted with 70% (v/v) hydroalcohic ethanol for 48 h. The extracts were filtered through filter paper Whatman No. 1 and were then concentrated with a rotary evaporator (40°C) to simplify its further process. The hydroalcohic extract was successively fractionated in to n-hexane (5.9%), ethyl acetate (5.9%), chloroform (16.7%) and aqueous (72.2%) fractions. The cell cultures have been treated with extracts at the concentrations ranging from 10 to 1000 µg/ml of hydroalcohic extract and 10 to 160 µg/ml of fractions. Maximal concentration of Demethyl sulfoxide (DMSO) added to cells was 0.1%, and the solvent was always used as control.
Cell line
Human umbilical vein endothelial cells (HUVEC) were purchased from Pasture Institute of Iran and grown in DMEM/F12 culture medium was supplemented with 10% of fetal calf serum, 100 IU ml⁻¹ penicillin and 100 µg ml⁻¹ streptomycint, then incubation at 37°C in a 5% CO2.
Human umbilical vein endothelial cells (HUVEC) capillary tube formation in three-dimensional collagen matrix
HUVECS were grown in DMEM/F12 supplemented with 10% FBS at 37ºC and 5% CO2. The cells were mixed with cytodex 3 microcarriers at a ratio of 30 cells per bead in 1 ml of DMEM/F12 medium (Auerbach et al., 2003) . Beads with cells were shaken gently every 20 min for 4 h at 37ºC and 5% CO2. The mixture were transferred to a 24-well tissue culture plate and left for 12 to 16 h in 1 ml of DMEM/F12 at 37ºC and 5% CO2. The following day, beads with cells re-suspended in type 1 collagen gel, and 50 μl of collagen/bead mixture was added to each well of a 96-well tissue culture plate and allowed to clot for 20 min at 37ºC, 5% CO2. Then, 250 μl of DMEM/F12 medium was added to each well and after 8 to 12 h different concentrations of the extracts were added. After 3 to 5 days of treatment, anti-angiogenic effects of the extracts were monitored microscopically (Keshavarz et al., 2010) .
Cytotoxicity assay
Cytotoxic concentrations were determined by growth of HUVECs in medium containing different concentrations of fractions (10, 20, 40, 80, 160 μg/ml). Cell viability was determined after 48 h of incubation, by LDH assays compared with controls.
The absorbance of converted dye in LDH assay was measured at wave length of 490 nm with background subtraction at 630 nm (Decker and Lohmann-Matthes, 1988 ).
Aint -proliferative assay
Anti-proliferative assay was performed (achived) on HUVECs because they are representative of microvascular endothelial cells. The cells were seeded on to a 24-wells culture plate at a density of 2×104 cells/well in DMEM/F12 supplemented with 10% FBS. After 24 h incubation at 37ºC and 5% CO2 (10, 20, 40, 80 and 160 µg/ml) of EA and NC fractions were added to the wells, and the cells were cultured for additional three days, then trypsinized and counted with cell counter (KX-21 SYSMEX Co.) against control wells.
Statistical analysis
The mean values were calculated for each group of concentrations and control. For the determination of the significance among the means, One way ANOVA test was applied (p< 0.05).
RESULTS
Angiogenesis, tightly modulated through a balance of positive and negative regulatory factors, is to operate by pro-angiogenic growth factors such as vascular endothelial growth factor (VEGF), which in turn induce activation of their respective receptors on the surface of endothelial cells, resulting in angiogenesis (HynuJooJung et al., 2006) . Therefore, identification of new agents that inhibit growth in endothelial cells could have potential to inhibit tumor angiogenesis and subsequently repress tumor growth. Three-dimensional culture of HUVECs is an in vitro model to screen the inhibitory activity of E. angustifolia and N. crispa extracts and its fractions on vascular development. After 3 to 5 days of treatment, untreated control wells gave branching pattern of tube like capillaries.
In contrast, capillary tube formation was strongly suppressed in wells which treated with E. angustifolia (200 to 1000 µg/ml) and N. crispa (400 to 1000 µg/ml) (Figure 1 ).
E. angustifolia flower and N. crispa aerial part were successively fractionated using hexane, ethyl acetate and chloroform to basically figure out the chemical characters of active principle(s) present in E. angustifolia and N. crispa . Among the obtained fractions, the ethyl acetate and chloroform fractions of both plant showed highest inhibitory activity at 10 µg/ml concentration (minimum concentration) on three-dimensional culture of HUVEC (Figures 2 and 3) .
E. angustifolia flower fractions in the range of 10 to 80 µg/ml concentration had no significant effect on the proliferation of HUVECs, but at 160 µg/ml and higher, a significant inhibition has been observed in cells proliferation (Figures 4 and 5) .
Among the used fractions, most reduction on cell proliferation was observed in N. crispa chloroform fraction in the range of 40 to 160 µg/ml. Aqueous fractions have no anti proliferation effects on HUVEC.
The E. angustifolia and N. crispa fractions could inhibit endothelial cell growth in a dose dependent manner (Figure 6 and 7) so their hexane, ethyl acetate and chloroform fractions in 80 and 160 µg/ml concentrations were significantly reduced survival cells. Furthermore, in these concentrations, inhibitory effect did not result from cytotoxic effect, as assessed by LDH cytotoxicity assays, compared with controls. Based on these criteria, many natural or synthetic chemicals were found to inhibit tumor angiogenesis (Singh and Agarwa, 2003) .
DISCUSSION
Tumorigenesis is a multi-step process where angiogenesis plays an important role in growth, progression and metastasis of all solid tumors. Therefore, the agents that inhibit angiogenesis could be effective in controlling primary growth and development of tumors as well as secondary metastatic tumors. Various strategies have been tested to inhibit endothelial cell proliferation and their survival (Agarwa and Singh, 2004) . Over the recent years, more attention has been focused on the anti-angiogenic and antineoplastic effects of non toxic compounds from natural products. Several antiangiogenic drugs are at present in different phases of clinical trials (Kerbel, 2000) .
The taken together E. angustifolia and N. crispa chloroform and ethyl acetate fractions at 200 and 400 µg/ml concentrations respectively, indiquant significative inhibitory effects on endotelial cell angiogenesis. Among the obtained fractions, the ethyl acetate and chloroform fractions of both plant showed highest inhibitory activity at 10 µg/ml concentration on three-dimensional culture of HUVEC. Fractions of E. angustifolia and N. crispa in these concentrations have not attribute toxicity and inhibition of human umbilica endothelial cell on endolelial cell, angiogenesis may contain major active antiangiogenic compound(s), as flavonoid responsible for anti-angiogenic properties of E. angustifolia and N. crispa.
However, based on these findings, further investigations are required to evaluate the in vivo antiangiogenic potential of EA and NC, especially in tumors for its possible usefulness in the prevention of growth and metastasis of tumors.
Conclusions
In conclusion, the present study demonstrated that E. angustifolia flower and N. crispa aerial part extracts at 200 and 400 µg/ml concentrations respectively could inhibit angiogenesis in HUVEC. Our results also showed that, the ethyl acetate and chloroform fractions of both E. angustifolia and N. crispa at 10 µg/ml concentration contains strong anti-angiogenic activity in vitro condition. It has been suggested that the use of quantitative angiogenesis assay in clinical trials may be helpful in the early detection of the disease and monitoring the efficacy of the agents under test (Bostwick and Iczkowski, 1998) . These findings provide additional pharmacological information of the therapeutic efficacy of E. angustifolia and N. crispa, and it would be considered as a novel starting point for the development of a new anti- angiogenic drugs.
